Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MLKL |
| Upstream (Parents) |
|---|
| (<<) ARHGAP25 → MLKL |
| (<<) CD274 → MLKL |
| (<<) CHST12 → MLKL |
| (<<) INPP5D → MLKL |
| (<<) IRF1 → MLKL |
| (<<) ITGB7 → MLKL |
| (<<) LPXN → MLKL |
| (<<) PIK3R5 → MLKL |
| (<<) STAT2 → MLKL |
| (<<) STAT4 → MLKL |
| (<<) UBE2L6 → MLKL |
| (<<) VAV1 → MLKL |
| (<<) ZBED2 → MLKL |
| Downstream (Children) |
|---|
| MLKL → ACTN1 (>>) |
| MLKL → ADCY7 (>>) |
| MLKL → CASP1 (>>) |
| MLKL → CASP10 (>>) |
| MLKL → CASP7 (>>) |
| MLKL → CNFN (>>) |
| MLKL → CRLF3 (>>) |
| MLKL → CSF2 (>>) |
| MLKL → CXADR (>>) |
| MLKL → DUSP2 (>>) |
| MLKL → FER1L4 (>>) |
| MLKL → GBP2 (>>) |
| MLKL → IL1RN (>>) |
| MLKL → ISG20 (>>) |
| MLKL → LRP8 (>>) |
| MLKL → MAP3K8 (>>) |
| MLKL → MEX3B (>>) |
| MLKL → PARP10 (>>) |
| MLKL → PPP1R15B (>>) |
| MLKL → PTK7 (>>) |
| MLKL → RPL26L1 (>>) |
| MLKL → SGK1 (>>) |
| MLKL → SH2D2A (>>) |
| MLKL → SOD2 (>>) |
| MLKL → TGM2 (>>) |
| MLKL → UBE2J1 (>>) |
